OBV/PTV/r + Sofosbuvir With or Without RBV for HCV Gt2 or 3 OBV/PTV/r + Sofosbuvir With or Without RBV for HCV Gt2 or 3

This study investigated the efficacy and safety of 12-week OBV/PTV/r + SOF with or without RBV in patients with HCV genotype 2 or 3 infection, including those with cirrhosis.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news